Massimo Calafiore - 03 Mar 2026 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
President & CEO, Director
Signature
/s/ J. Andres Cedron, attorney-in-fact
Issuer symbol
OFIX
Transactions as of
03 Mar 2026
Net transactions value
$0
Form type
4
Filing time
05 Mar 2026, 18:52:33 UTC
Previous filing
13 Jan 2026
Next filing
06 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Calafiore Massimo President & CEO, Director 3451 PLANO PARKWAY, LEWISVILLE /s/ J. Andres Cedron, attorney-in-fact 05 Mar 2026 0001828602

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award +115,119 +53% $0.000000* 332,356 03 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OFIX Employee Stock Option (Right to Buy) Award +273,279 $0.000000* 273,279 03 Mar 2026 Common Stock 273,279 $13.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.
F2 Includes 135,369 previously reported restricted stock units.
F3 The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.